These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 22753716)
1. A significant role of lipogenic enzymes in colorectal cancer. Notarnicola M; Messa C; Caruso MG Anticancer Res; 2012 Jul; 32(7):2585-90. PubMed ID: 22753716 [TBL] [Abstract][Full Text] [Related]
2. Fatty acid synthase hyperactivation in human colorectal cancer: relationship with tumor side and sex. Notarnicola M; Altomare DF; Calvani M; Orlando A; Bifulco M; D'Attoma B; Caruso MG Oncology; 2006; 71(5-6):327-32. PubMed ID: 17687193 [TBL] [Abstract][Full Text] [Related]
3. Biochemical changes of mevalonate pathway in human colorectal cancer. Caruso MG; Notarnicola M Anticancer Res; 2005; 25(5):3393-7. PubMed ID: 16101154 [TBL] [Abstract][Full Text] [Related]
4. Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis. Menendez JA; Ropero S; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Jun; 24(6):1369-83. PubMed ID: 15138577 [TBL] [Abstract][Full Text] [Related]
5. Low levels of lipogenic enzymes in peritumoral adipose tissue of colorectal cancer patients. Notarnicola M; Miccolis A; Tutino V; Lorusso D; Caruso MG Lipids; 2012 Jan; 47(1):59-63. PubMed ID: 22090062 [TBL] [Abstract][Full Text] [Related]
6. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
7. Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids? Menendez JA; Colomer R; Lupu R Med Hypotheses; 2005; 64(2):342-9. PubMed ID: 15607569 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis. Menendez JA; Colomer R; Lupu R Med Hypotheses; 2005; 64(2):337-41. PubMed ID: 15607568 [TBL] [Abstract][Full Text] [Related]
9. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells. Menendez JA; Lupu R Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825 [TBL] [Abstract][Full Text] [Related]
10. RNA interference-mediated silencing of the acetyl-CoA-carboxylase-alpha gene induces growth inhibition and apoptosis of prostate cancer cells. Brusselmans K; De Schrijver E; Verhoeven G; Swinnen JV Cancer Res; 2005 Aug; 65(15):6719-25. PubMed ID: 16061653 [TBL] [Abstract][Full Text] [Related]
11. Sterol regulatory element-binding protein-1 participates in the regulation of fatty acid synthase expression in colorectal neoplasia. Li JN; Mahmoud MA; Han WF; Ripple M; Pizer ES Exp Cell Res; 2000 Nov; 261(1):159-65. PubMed ID: 11082286 [TBL] [Abstract][Full Text] [Related]
12. Higher farnesyl diphosphate synthase activity in human colorectal cancer inhibition of cellular apoptosis. Notarnicola M; Messa C; Cavallini A; Bifulco M; Tecce MF; Eletto D; Di Leo A; Montemurro S; Laezza C; Caruso MG Oncology; 2004; 67(5-6):351-8. PubMed ID: 15713990 [TBL] [Abstract][Full Text] [Related]
13. Characterization and inhibition of fatty acid synthase in pediatric tumor cell lines. Slade RF; Hunt DA; Pochet MM; Venema VJ; Hennigar RA Anticancer Res; 2003; 23(2B):1235-43. PubMed ID: 12820377 [TBL] [Abstract][Full Text] [Related]
14. [Metabolic and regulatory function of fatty acid synthase]. Swierczyński J; Sledziński T Postepy Biochem; 2012; 58(2):175-85. PubMed ID: 23214141 [TBL] [Abstract][Full Text] [Related]
15. Plasma interleukin-6 is not a mediator of changes in lipoprotein lipase activity in cancer patients. Nomura K; Noguchi Y; Yoshikawa T; Kondo J Hepatogastroenterology; 1997; 44(17):1519-26. PubMed ID: 9356883 [TBL] [Abstract][Full Text] [Related]
16. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target. Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830 [TBL] [Abstract][Full Text] [Related]
17. Control of cell growth and survival by enzymes of the fatty acid synthesis pathway in HCT-116 colon cancer cells. Zhan Y; Ginanni N; Tota MR; Wu M; Bays NW; Richon VM; Kohl NE; Bachman ES; Strack PR; Krauss S Clin Cancer Res; 2008 Sep; 14(18):5735-42. PubMed ID: 18794082 [TBL] [Abstract][Full Text] [Related]